Andrey Loboda
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 24
- Colorectal Cancer Treatments and Studies 15
- Pancreatic and Hepatic Oncology Research 7
- Immunology top 1%
- Immunotherapy and Immune Responses 6
- T-cell and Retrovirus Studies 5
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 15
-
- Gastric Cancer Management and Outcomes 7
- Lung Cancer Treatments and Mutations 6
- Molecular Biology top 5%
- Co-authors
- Michael NebozhynJared LuncefordMark AyersAndrew AlbrightAntoni RibasErin MurphyJennifer H. YearleyJonathan D. Cheng
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)Nature Communications (2 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Andrey Loboda
75 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 3.6k
- Immunology 1.9k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 2.3k
Countries citing papers authored by Andrey Loboda
This map shows the geographic impact of Andrey Loboda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey Loboda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey Loboda more than expected).
Fields of papers citing papers by Andrey Loboda
This network shows the impact of papers produced by Andrey Loboda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey Loboda. The network helps show where Andrey Loboda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrey Loboda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 40 | |
| 3 | 2021 | 40 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 51 | |
| 6 | 2020 | 190 | |
| 7 | 2020 | 2 | |
| 8 | 2018 | 27 | |
| 9 | 2016 | 16 | |
| 10 | 2016 | 227 | |
| 11 | 2016 | 152 | |
| 12 | 2015 | 30 | |
| 13 | 2015 | 73 | |
| 14 | 2014 | 24 | |
| 15 | 2011 | 26 | |
| 16 | 2011 | 58 | |
| 17 | 2009 | 283 | |
| 18 | 2009 | 13 | |
| 19 | 2008 | 138 | |
| 20 | Mechanisms of in vitro acquired resistance to vorinostat (suberoylanilide hydroxamic acid, SAHA) | 2007 | 3 |
About Andrey Loboda
Andrey Loboda is a scholar working on Oncology, Cancer Research and Immunology, having authored 78 papers that have together received 6.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Cancer Genomics and Diagnostics (15 papers), Colorectal Cancer Treatments and Studies (15 papers), Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (7 papers), Immunotherapy and Immune Responses (6 papers), Lung Cancer Treatments and Mutations (6 papers) and T-cell and Retrovirus Studies (5 papers). The work is most often cited by research in Oncology (3.6k citations), Immunology (1.9k citations) and Cancer Research (1.1k citations). Andrey Loboda has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Michael Nebozhyn, Jared Lunceford, Mark Ayers, Andrew Albright, Antoni Ribas, Erin Murphy, Jennifer H. Yearley, Jonathan D. Cheng, Terrill K. McClanahan and David R. Kaufman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.